In the BM group, HCC recurrence-free survival rates at 3 and 5 years for patients with AFP ≤ 400 ng/mL were 71.6% and 68.4%, while those for patients with AFP > 400 ng/mL were 27.5% and 27.5%, respectively (p < 0.05) (Figure 3). The gene discussed is AFP; the disease is hepatocellular carcinoma.